LGALS9 and type 1 diabetes mellitus: It has been suggested that the absence of co-suppressive immune checkpoint ligands (e.g. PD-L1, HLA-E, CD86, and Gal-9) in β-cells in PR can significantly affect the development of T1D (12–14).